| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
7,346 |
6,157 |
$365K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,158 |
974 |
$85K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
3,450 |
2,835 |
$73K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,154 |
927 |
$61K |
| S9088 |
Services provided in an urgent care center (list in addition to code for service) |
888 |
842 |
$48K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,215 |
1,038 |
$42K |
| 99215 |
Prolong outpt/office vis |
530 |
453 |
$38K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
937 |
775 |
$21K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,358 |
1,042 |
$19K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,068 |
917 |
$10K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
76 |
69 |
$6K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
125 |
107 |
$2K |
| 99205 |
Prolong outpt/office vis |
18 |
12 |
$1K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
232 |
197 |
$923.53 |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
30 |
12 |
$523.69 |
| 87430 |
|
51 |
49 |
$501.87 |
| S9083 |
Global fee urgent care centers |
70 |
68 |
$0.00 |